Thomas A. Dineen

948 total citations
12 papers, 397 citations indexed

About

Thomas A. Dineen is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Thomas A. Dineen has authored 12 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Thomas A. Dineen's work include Alzheimer's disease research and treatments (4 papers), Chemical Synthesis and Analysis (3 papers) and Cancer therapeutics and mechanisms (2 papers). Thomas A. Dineen is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Chemical Synthesis and Analysis (3 papers) and Cancer therapeutics and mechanisms (2 papers). Thomas A. Dineen collaborates with scholars based in United States, South Korea and Japan. Thomas A. Dineen's co-authors include Andrew G. Myers, Matthew Zajac, William Roush, Robert C. Wahl, Vinod F. Patel, Alan C. Cheng, Paul H. Wen, Stephen Wood, O. I. Epstein and Robert T. Fremeau and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas A. Dineen

12 papers receiving 391 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas A. Dineen	302	173	86	61	57	12	397
Malken Bayrakdarian	239 0.8×	146 0.8×	47 0.5×	62 1.0×	42 0.7×	17	390
Matthew P. Bourbeau	302 1.0×	142 0.8×	58 0.7×	36 0.6×	40 0.7×	16	433
A. Mayweg	308 1.0×	189 1.1×	117 1.4×	28 0.5×	43 0.8×	19	576
Nathan O. Fuller	121 0.4×	161 0.9×	60 0.7×	42 0.7×	55 1.0×	18	330
Matthew M. Weiss	527 1.7×	141 0.8×	74 0.9×	69 1.1×	35 0.6×	22	676
Robert M. Rzasa	326 1.1×	149 0.9×	73 0.8×	25 0.4×	17 0.3×	16	499
Hiroyuki Sugumi	348 1.2×	189 1.1×	114 1.3×	26 0.4×	73 1.3×	11	474
Alan M. Birch	191 0.6×	165 1.0×	32 0.4×	18 0.3×	33 0.6×	20	402
Hossein Razavi	339 1.1×	287 1.7×	70 0.8×	24 0.4×	16 0.3×	11	535
Ana B. Bueno	210 0.7×	323 1.9×	38 0.4×	19 0.3×	62 1.1×	24	599

Countries citing papers authored by Thomas A. Dineen

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Dineen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Dineen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Dineen more than expected).

Fields of papers citing papers by Thomas A. Dineen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Dineen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Dineen. The network helps show where Thomas A. Dineen may publish in the future.

Co-authorship network of co-authors of Thomas A. Dineen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Dineen. A scholar is included among the top collaborators of Thomas A. Dineen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Dineen. Thomas A. Dineen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lim, Sun Min, Stefanie S. Schalm, Sewon Park, et al.. (2024). BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer. Therapeutic Advances in Medical Oncology. 16. 7 indexed citations

Epstein, O. I., Marian C. Bryan, Alan C. Cheng, et al.. (2014). Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. Journal of Medicinal Chemistry. 57(23). 9796–9810. 32 indexed citations

Dineen, Thomas A., Kui Chen, Alan C. Cheng, et al.. (2014). Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718). Journal of Medicinal Chemistry. 57(23). 9811–9831. 49 indexed citations

Wood, Stephen, Paul H. Wen, Jianhua Zhang, et al.. (2012). Establishing the Relationship between In Vitro Potency, Pharmacokinetic, and Pharmacodynamic Parameters in a Series of Orally Available, Hydroxyethylamine-Derived β-Secretase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 343(2). 460–467. 8 indexed citations

Huang, Hongbing, Daniel S. La, Alan C. Cheng, et al.. (2012). Structure- and Property-Based Design of Aminooxazoline Xanthenes as Selective, Orally Efficacious, and CNS Penetrable BACE Inhibitors for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry. 55(21). 9156–9169. 51 indexed citations

Michaelis, David J. & Thomas A. Dineen. (2009). Ring opening of aziridines with ortho-bromophenyl metal reagents: synthesis of 2-substituted indolines. Tetrahedron Letters. 50(17). 1920–1923. 14 indexed citations

Dineen, Thomas A., Matthew Zajac, & Andrew G. Myers. (2007). Efficient Transamidation of Primary Carboxamides by in situ Activation with N,N‐Dialkylformamide Dimethyl Acetals.. ChemInform. 38(17). 3 indexed citations

Dineen, Thomas A., Matthew Zajac, & Andrew G. Myers. (2006). Efficient Transamidation of Primary Carboxamides by in Situ Activation with N,N-Dialkylformamide Dimethyl Acetals. Journal of the American Chemical Society. 128(50). 16406–16409. 138 indexed citations

Dineen, Thomas A. & William Roush. (2005). Stereoselective Synthesis of the Octahydronaphthalene Unit of Integramycin via an Intramolecular Diels−Alder Reaction. Organic Letters. 7(7). 1355–1358. 22 indexed citations

10.

Dineen, Thomas A. & William Roush. (2004). Total Synthesis of Cochleamycin A. Organic Letters. 6(12). 2043–2046. 46 indexed citations

11.

Boitano, Anthony E., Cory D. Emal, Francesco Leonetti, et al.. (2003). Structure activity studies of a novel cytotoxic benzodiazepine. Bioorganic & Medicinal Chemistry Letters. 13(19). 3327–3330. 11 indexed citations

12.

Dineen, Thomas A. & William Roush. (2003). Probing the Lewis Acid-Catalyzed Intramolecular Diels−Alder Cyclizations of Allylic Alkoxy-Substituted (Z)-1,3-Dienes. Organic Letters. 5(24). 4725–4728. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact